
Basler (BSLG) shares climbed 7% after the company reported improved Q2 order intake, reaching a 1.2x book-to-bill ratio, and subsequently raised its full-year 2025 EBT guidance to €8.3 million, approximately 30% above previous consensus. Despite this, Q2 revenues were sequentially lower at €52.2 million, and gross margin compression to 46.2% due to factors including higher U.S. tariffs led to a sharp EBT margin decline to 3.6%. The raised full-year EBT guidance, following €7.9 million in H1 EBT, implies minimal profitability for the remainder of 2025, with management anticipating continued market challenges from political uncertainties and trade headwinds.
Basler's stock rose 7% following a significant improvement in its second-quarter order intake to €61.2 million, which elevated its book-to-bill ratio to 1.2x from 0.9x in the prior quarter. This strength prompted management to raise its full-year 2025 earnings before taxes (EBT) guidance to a midpoint of €8.3 million, approximately 30% above consensus. However, this positive forward-looking data is contrasted by deteriorating operational performance in Q2. Revenues declined 12% sequentially to €52.2 million, and gross margin compressed significantly by 192 basis points quarter-over-quarter to 46.2%, partially due to higher U.S. tariffs. Consequently, the EBT margin plummeted from 10.0% in Q1 to just 3.6% in Q2. Critically, the revised full-year EBT guidance implies minimal profitability for the second half of 2025, as the company has already achieved €7.9 million in EBT in the first half. This outlook is consistent with management's explicit warnings of a challenging environment ahead, citing political uncertainties, trade headwinds, and adverse foreign exchange effects.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment